Skip to main content
. 2018 Apr 17;141(6):1828–1839. doi: 10.1093/brain/awy103

Figure 5.

Figure 5

Characterization of abnormal levels of amyloid-β PET across the lifespan. The proportion of APOE ɛ4 carriers and non-carriers who are amyloid-β PET positive is depicted as function of age in (A) non-demented individuals only and (B) the combined sample of non-demented and demented individuals.